Reply to ‘Comment on ‘A meta-analysis of CXCL12 expression for cancer prognosis”

Literature searching concerns. Dr Zu-Bing Mei et al (2018) identify two studies that they claim are not included in our analysis despite meeting the inclusion criteria. Furthermore, they indicate that had these articles been included, the results of our meta-analysis may have been different. In order to clarify, we would like to point out that one of the cited articles (Saigusa et al, 2010) was identified by our search strategy; however, the authors did not include sufficient data for inclusion in our meta-analysis. The authors were contacted by email but did not respond to our request for further data. The second study identified by Mei et al (Yu et al, 2016) was not identified by our search strategy. This is likely because it was published in the same month as we ran our search strategy and therefore may not have been indexed at that time. On review of (Yu et al, 2016), the article reports on 54 osteosarcoma patients, demonstrating a significant association between elevated CXCL12 expression and overall survival (HR 2.64 (1.12–6.20)). This is a small study and the resultant effect estimate is associated with a reasonably wide confidence interval; it is unlikely to have significantly altered our overall survival estimates.

• Publication year

  2018

• Venue

  British Journal of Cancer

• Publication date

  2018-01-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bjc.2017.445PMID 29301142PMCID 5808041
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comment on ‘A meta-analysis of CXCL12 expression for cancer prognosis’

  2018cited by this paper
• A meta-analysis of CXCL12 expression for cancer prognosis

  2017cited by this paper
• SDF-1 Expression is Associated with Poor Prognosis in Osteosarcoma.

  2016influential reference
• Stromal CXCR4 and CXCL12 Expression is Associated with Distant Recurrence and Poor Prognosis in Rectal Cancer After Chemoradiotherapy

  2010cited by this paper
• Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors.

  2004cited by this paper

• No citing papers are available for this paper.